Molecular testing for infectious diseases uses advanced nucleic acid amplification techniques, such as PCR and real-time PCR, to detect the genetic material of viruses,
bacteria, and fungi with high sensitivity and specificity. These tests enable early and
accurate diagnosis, even in low pathogen loads, guiding timely and targeted treatment
while reducing inappropriate antibiotic use. Rapid syndromic testing panels further enhance patient care by simultaneously identifying multiple pathogens and resistance markers from a single sample—delivering results in hours instead of days. This approach supports faster clinical decision-making, limits disease spread, and improves patient outcomes across critical care, outpatient, and public health settings.
